Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs FBIOX overlap: 20% of top holdings shared

Bottom line

How much do XBI and FBIOX overlap?

20% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 9.6% of XBI's assets and 21.5% of FBIOX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIFBIOX
Weight overlap (top 25)20%
Shared holdings8
Weight in shared holdings9.6%21.5%
Total positions161215
Expense ratio0.35%0.62%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings XBI and FBIOX have in common

Holding% of XBI% of FBIOXOverlap
Moderna Inc1.41%1.28%1.28%
Praxis Precision Medicines Inc1.29%2.47%1.29%
Revolution Medicines Inc1.20%2.02%1.20%
Natera Inc1.16%1.41%1.16%
Scholar Rock Holding Corp1.16%1.55%1.16%
Roivant Sciences Ltd1.16%1.13%1.13%
Cogent Biosciences Inc1.14%1.07%1.07%
Krystal Biotech Inc1.10%10.58%1.10%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Twist Bioscience Corp — 1.41%
  4. Oruka Therapeutics Inc — 1.38%
  5. Kymera Therapeutics Inc — 1.36%
  6. Viking Therapeutics Inc — 1.30%
  7. Erasca Inc — 1.27%
  8. Rhythm Pharmaceuticals Inc — 1.20%
  9. CG oncology Inc — 1.20%
  10. SELLAS Life Sciences Group Inc — 1.19%
  11. Vaxcyte Inc — 1.19%
  12. Dianthus Therapeutics Inc — 1.18%
  13. Cytokinetics Inc — 1.18%
  14. Mirum Pharmaceuticals Inc — 1.16%
  15. Ultragenyx Pharmaceutical Inc — 1.14%

Only in FBIOX

  1. Abbvie Inc — 9.22%
  2. Amgen Inc — 6.53%
  3. Gilead Sciences Inc — 4.82%
  4. Fidelity Revere Street Trust — 3.35%
  5. Alnylam Pharmaceuticals Inc — 2.93%
  6. Insmed Inc — 2.25%
  7. Argenx Se — 2.25%
  8. Ascendis Pharma A/s — 2.04%
  9. Ucb Sa — 2.00%
  10. Jazz Pharmaceuticals Plc — 1.84%
  11. Axsome Therapeutics Inc — 1.28%
  12. Biogen Inc — 1.26%
  13. Protagonist Therapeutics Inc — 1.15%
  14. Tango Therapeutics Inc — 0.98%
  15. Celcuity Inc — 0.95%

Asset mix

Asset typeXBIFBIOX
Stocks99.9%99.0%
Cash & short-term funds5.9%3.5%
Preferred stock—0.9%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryXBIFBIOX
US100.8%88.5%
NL1.0%2.9%
DK—2.6%
BE—2.0%
IE1.2%2.0%
BM1.2%1.1%
CH1.0%1.1%
FR—0.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do XBI and FBIOX overlap?
About 20% by weight. 8 securities appear in both funds' top 25 holdings; they make up 9.6% of XBI's assets and 21.5% of FBIOX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and FBIOX have in common?
The largest shared holdings are Praxis Precision Medicines Inc, Moderna Inc, Revolution Medicines Inc, Natera Inc, Scholar Rock Holding Corp.
Should I own both XBI and FBIOX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or FBIOX?
FBIOX is broader, with 215 positions versus 161 for XBI. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.